Cost-effectiveness with PCSK9 inhibitors: a matter of costs.
Options
BORIS DOI
Publisher DOI
PubMed ID
29315397
Date of Publication
2018-01-01
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Additional Credits
Series
European heart journal - cardiovascular pharmacotherapy
Publisher
Oxford University Press
ISSN
2055-6837
Access(Rights)
open.access